Welcome to LookChem.com Sign In|Join Free

CAS

  • or

6084-58-8

Post Buying Request

6084-58-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

6084-58-8 Usage

Uses

O-Isobutylhydroxylamine Hydrochloride is a reagent in the preparation of bis-hydroxy-benzophenone oxime ether derivatives as estrogen receptor (ER) agonist with complementary anti-cancer activities.

Check Digit Verification of cas no

The CAS Registry Mumber 6084-58-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,0,8 and 4 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 6084-58:
(6*6)+(5*0)+(4*8)+(3*4)+(2*5)+(1*8)=98
98 % 10 = 8
So 6084-58-8 is a valid CAS Registry Number.
InChI:InChI=1/C4H11NO.ClH/c1-4(2)3-6-5;/h4H,3,5H2,1-2H3;1H

6084-58-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Isobutyloxyamine Hydrochloride

1.2 Other means of identification

Product number -
Other names O-(2-methylpropyl)hydroxylamine,hydrochloride

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:6084-58-8 SDS

6084-58-8Synthetic route

O-1-(2-methyl)propyl-N-hydroxyphthalimide
52026-51-4

O-1-(2-methyl)propyl-N-hydroxyphthalimide

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

Conditions
ConditionsYield
Stage #1: O-1-(2-methyl)propyl-N-hydroxyphthalimide With methylhydrazine In dichloromethane at 0 - 20℃; for 2h;
Stage #2: With hydrogenchloride In 1,4-dioxane at 0℃;
99%
With hydrazine In ethanol; water for 2h; hydrazinolysis; Heating;31.9%
With methylhydrazine In dichloromethane
Stage #1: O-1-(2-methyl)propyl-N-hydroxyphthalimide With hydrazine hydrate In dichloromethane Inert atmosphere;
Stage #2: With hydrogenchloride In 1,4-dioxane Inert atmosphere;
C6H13NO2

C6H13NO2

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water at 65℃;61.8%
With hydrogenchloride In ethanol; water at 65℃;61.8%
C13H15NO2

C13H15NO2

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

Conditions
ConditionsYield
Stage #1: C13H15NO2 With hydrazine hydrate In tetrahydrofuran at 20℃; for 12h;
Stage #2: With hydrogenchloride In 1,4-dioxane at 20℃; for 0.0833333h;
53%
O-isobutylhydroxylamine
5618-62-2

O-isobutylhydroxylamine

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In ethanol at 0 - 5℃; for 72h;
4,4'-Dihydroxybenzophenone
611-99-4

4,4'-Dihydroxybenzophenone

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

bis(4-hydroxyphenyl)methanone O-isobutyl oxime

bis(4-hydroxyphenyl)methanone O-isobutyl oxime

Conditions
ConditionsYield
In ethanol at 20℃; Inert atmosphere;99%
2,7-bis(N'-ethoxycarbonylthiourea)-9H-fluorene
853579-43-8

2,7-bis(N'-ethoxycarbonylthiourea)-9H-fluorene

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

2,7-bis(N'-ethoxycarbonyl-N''-isobutoxy)guanidino-9H-fluorene
853579-28-9

2,7-bis(N'-ethoxycarbonyl-N''-isobutoxy)guanidino-9H-fluorene

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In 1,4-dioxane; dichloromethane at 20℃;93%
methyl 2-(4-hydroxybenzyl)-3-oxobutanoate
157284-85-0

methyl 2-(4-hydroxybenzyl)-3-oxobutanoate

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

3-(2-methyl-propyl)oxyimino-2-(4-hydroxy-benzyl)-butyric acid methyl ester
851181-35-6

3-(2-methyl-propyl)oxyimino-2-(4-hydroxy-benzyl)-butyric acid methyl ester

Conditions
ConditionsYield
With sodium acetate In methanol90%
With triethylamine In ethanol at 45℃; for 24h;80%
methyl 3-acetyl-5-(dipropylcarbamoyl)-benzoate
924650-01-1

methyl 3-acetyl-5-(dipropylcarbamoyl)-benzoate

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

C21H32N2O4
1163142-89-9

C21H32N2O4

Conditions
ConditionsYield
In ethanol at 80℃;85%
O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

benzyl chloroformate
501-53-1

benzyl chloroformate

benzyl N-(isobutyloxy)carbamate
1174758-23-6

benzyl N-(isobutyloxy)carbamate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; Inert atmosphere;84%
C31H44O7
1446092-98-3

C31H44O7

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

((2R,3S)-3-acetoxy-6-((3S,10R,13S,17S)-17-((E)-1-(isobutoxyimino)ethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)-3,6-dihydro-2H-pyran-2-yl)methyl acetate

((2R,3S)-3-acetoxy-6-((3S,10R,13S,17S)-17-((E)-1-(isobutoxyimino)ethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)-3,6-dihydro-2H-pyran-2-yl)methyl acetate

Conditions
ConditionsYield
With pyridine for 3h; Reflux;84%
C31H44O7
1446092-98-3

C31H44O7

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

C35H53NO7

C35H53NO7

Conditions
ConditionsYield
With pyridine at 80℃; for 4h; Inert atmosphere;84%
C32H48O9

C32H48O9

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

C36H57NO9

C36H57NO9

Conditions
ConditionsYield
With pyridine at 20℃;80%
4-chloro-2-pyridine carboxylic acid chloride hydrochloride

4-chloro-2-pyridine carboxylic acid chloride hydrochloride

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

4-chloro-N-isobutoxypicolinamide
953771-92-1

4-chloro-N-isobutoxypicolinamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃; for 0.5h;67%
[(S)-2-Benzyl-4-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazin-1-yl]-acetic acid

[(S)-2-Benzyl-4-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazin-1-yl]-acetic acid

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

2-[(S)-2-Benzyl-4-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazin-1-yl]-N-isobutoxy-acetamide

2-[(S)-2-Benzyl-4-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazin-1-yl]-N-isobutoxy-acetamide

Conditions
ConditionsYield
Stage #1: [(S)-2-Benzyl-4-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazin-1-yl]-acetic acid With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran; dichloromethane at 0℃; for 0.0833333h;
Stage #2: O-isobutylhydroxylamine hydrochloride With triethylamine In tetrahydrofuran; dichloromethane at 0℃; for 16h;
67%
O-1-(2-methyl)propyl-N-hydroxyphthalimide
52026-51-4

O-1-(2-methyl)propyl-N-hydroxyphthalimide

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

Conditions
ConditionsYield
Stage #1: O-1-(2-methyl)propyl-N-hydroxyphthalimide With methylhydrazine In dichloromethane at 0 - 20℃; for 2h;
Stage #2: With hydrogenchloride In 1,4-dioxane at 0℃;
99%
With hydrazine In ethanol; water for 2h; hydrazinolysis; Heating;31.9%
With methylhydrazine In dichloromethane
Stage #1: O-1-(2-methyl)propyl-N-hydroxyphthalimide With hydrazine hydrate In dichloromethane Inert atmosphere;
Stage #2: With hydrogenchloride In 1,4-dioxane Inert atmosphere;
C6H13NO2

C6H13NO2

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In ethanol; water at 65℃;61.8%
With hydrogenchloride In ethanol; water at 65℃;61.8%
C13H15NO2

C13H15NO2

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

Conditions
ConditionsYield
Stage #1: C13H15NO2 With hydrazine hydrate In tetrahydrofuran at 20℃; for 12h;
Stage #2: With hydrogenchloride In 1,4-dioxane at 20℃; for 0.0833333h;
53%
O-isobutylhydroxylamine
5618-62-2

O-isobutylhydroxylamine

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

Conditions
ConditionsYield
With hydrogenchloride In ethanol at 0 - 5℃; for 72h;
4,4'-Dihydroxybenzophenone
611-99-4

4,4'-Dihydroxybenzophenone

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

bis(4-hydroxyphenyl)methanone O-isobutyl oxime

bis(4-hydroxyphenyl)methanone O-isobutyl oxime

Conditions
ConditionsYield
In ethanol at 20℃; Inert atmosphere;99%
2,7-bis(N'-ethoxycarbonylthiourea)-9H-fluorene
853579-43-8

2,7-bis(N'-ethoxycarbonylthiourea)-9H-fluorene

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

2,7-bis(N'-ethoxycarbonyl-N''-isobutoxy)guanidino-9H-fluorene
853579-28-9

2,7-bis(N'-ethoxycarbonyl-N''-isobutoxy)guanidino-9H-fluorene

Conditions
ConditionsYield
With 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine In 1,4-dioxane; dichloromethane at 20℃;93%
methyl 2-(4-hydroxybenzyl)-3-oxobutanoate
157284-85-0

methyl 2-(4-hydroxybenzyl)-3-oxobutanoate

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

3-(2-methyl-propyl)oxyimino-2-(4-hydroxy-benzyl)-butyric acid methyl ester
851181-35-6

3-(2-methyl-propyl)oxyimino-2-(4-hydroxy-benzyl)-butyric acid methyl ester

Conditions
ConditionsYield
With sodium acetate In methanol90%
With triethylamine In ethanol at 45℃; for 24h;80%
methyl 3-acetyl-5-(dipropylcarbamoyl)-benzoate
924650-01-1

methyl 3-acetyl-5-(dipropylcarbamoyl)-benzoate

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

C21H32N2O4
1163142-89-9

C21H32N2O4

Conditions
ConditionsYield
In ethanol at 80℃;85%
O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

benzyl chloroformate
501-53-1

benzyl chloroformate

benzyl N-(isobutyloxy)carbamate
1174758-23-6

benzyl N-(isobutyloxy)carbamate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In dichloromethane at 0 - 20℃; Inert atmosphere;84%
C31H44O7
1446092-98-3

C31H44O7

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

((2R,3S)-3-acetoxy-6-((3S,10R,13S,17S)-17-((E)-1-(isobutoxyimino)ethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)-3,6-dihydro-2H-pyran-2-yl)methyl acetate

((2R,3S)-3-acetoxy-6-((3S,10R,13S,17S)-17-((E)-1-(isobutoxyimino)ethyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yloxy)-3,6-dihydro-2H-pyran-2-yl)methyl acetate

Conditions
ConditionsYield
With pyridine for 3h; Reflux;84%
C31H44O7
1446092-98-3

C31H44O7

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

C35H53NO7

C35H53NO7

Conditions
ConditionsYield
With pyridine at 80℃; for 4h; Inert atmosphere;84%
C32H48O9

C32H48O9

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

C36H57NO9

C36H57NO9

Conditions
ConditionsYield
With pyridine at 20℃;80%
4-chloro-2-pyridine carboxylic acid chloride hydrochloride

4-chloro-2-pyridine carboxylic acid chloride hydrochloride

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

4-chloro-N-isobutoxypicolinamide
953771-92-1

4-chloro-N-isobutoxypicolinamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 20℃; for 0.5h;67%
[(S)-2-Benzyl-4-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazin-1-yl]-acetic acid

[(S)-2-Benzyl-4-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazin-1-yl]-acetic acid

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

2-[(S)-2-Benzyl-4-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazin-1-yl]-N-isobutoxy-acetamide

2-[(S)-2-Benzyl-4-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazin-1-yl]-N-isobutoxy-acetamide

Conditions
ConditionsYield
Stage #1: [(S)-2-Benzyl-4-(3-cyclopentyloxy-4-methoxy-phenyl)-piperazin-1-yl]-acetic acid With dmap; dicyclohexyl-carbodiimide In tetrahydrofuran; dichloromethane at 0℃; for 0.0833333h;
Stage #2: O-isobutylhydroxylamine hydrochloride With triethylamine In tetrahydrofuran; dichloromethane at 0℃; for 16h;
67%
4,5-dichloro-6-methyl-2-(6-methyl-pyridin-2-yl)-pyrimidine

4,5-dichloro-6-methyl-2-(6-methyl-pyridin-2-yl)-pyrimidine

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

5-Chloro-4-O-isobutylhydroxylamino-6-methyl-2-(6-methyl-2-pyridyl)-pyrimidine
156825-31-9

5-Chloro-4-O-isobutylhydroxylamino-6-methyl-2-(6-methyl-2-pyridyl)-pyrimidine

Conditions
ConditionsYield
With triethylamine In ethanol65%
N-[6-(3-amino-4-fluorophenoxy)imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
1005781-39-4

N-[6-(3-amino-4-fluorophenoxy)imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

1,1'-carbonyldiimidazole
530-62-1

1,1'-carbonyldiimidazole

N-[6-(4-fluoro-3-{[(isobutoxyamino)carbonyl]amino}phenoxy)imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide
1005783-24-3

N-[6-(4-fluoro-3-{[(isobutoxyamino)carbonyl]amino}phenoxy)imidazo[1,2-b]pyridazin-2-yl]cyclopropanecarboxamide

Conditions
ConditionsYield
With triethylamine In N,N-dimethyl-formamide63%
4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-2-pyridinecarboxylic acid

4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-2-pyridinecarboxylic acid

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-N-(2-methylpropoxy)picolinamide
1242164-27-7

4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)-N-(2-methylpropoxy)picolinamide

Conditions
ConditionsYield
Stage #1: 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid; O-isobutylhydroxylamine hydrochloride With dmap; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In 1,2-dichloro-ethane at 23℃; for 18h;
Stage #2: With acetic acid In 1,2-dichloro-ethane
61%
stigmast-4-ene-3,6-dione
23670-94-2

stigmast-4-ene-3,6-dione

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

A

C33H55NO2

C33H55NO2

B

C37H64N2O2

C37H64N2O2

Conditions
ConditionsYield
With sodium acetate In ethanol at 45℃;A 41.1%
B 51.3%
stigmast-4-ene-3,6-dione
23670-94-2

stigmast-4-ene-3,6-dione

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

A

C33H55NO2

C33H55NO2

B

C37H64N2O2

C37H64N2O2

Conditions
ConditionsYield
With sodium acetate In ethanol Heating;A 41.1%
B 51.3%
Ph(3-Cl)(5-OCF3)-(R)CH(OH)C(O)-Aze-Pab(Teoc)
433938-50-2

Ph(3-Cl)(5-OCF3)-(R)CH(OH)C(O)-Aze-Pab(Teoc)

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

Ph(3-Cl)(5-OCF3)-(R)CH(OH)C(O)-Aze-Pab(OiBu)
433938-52-4

Ph(3-Cl)(5-OCF3)-(R)CH(OH)C(O)-Aze-Pab(OiBu)

Conditions
ConditionsYield
Stage #1: Ph(3-Cl)(5-OCF3)-(R)CH(OH)C(O)-Aze-Pab(Teoc); O-isobutylhydroxylamine hydrochloride In acetonitrile at 60℃;
Stage #2: With trifluoroacetic acid In dichloromethane at 20℃; for 3h;
45%
(3-chloro-4-methanesulfonyl-phenyl)-oxo-acetic acid methyl ester
393165-03-2

(3-chloro-4-methanesulfonyl-phenyl)-oxo-acetic acid methyl ester

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

(E)-(3-chloro-4-methanesulfonyl-phenyl)-isobutoxyimino-acetic acid methyl ester
1033780-30-1

(E)-(3-chloro-4-methanesulfonyl-phenyl)-isobutoxyimino-acetic acid methyl ester

Conditions
ConditionsYield
In methanol at 70℃; for 3h;35%
mitomycin A
4055-39-4

mitomycin A

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

<1aS-(1aα,8β,8aα,8bα)>-8<<(aminocarbonyl)oxy>methyl>-6-(isobutyloxy)imino-8a-methoxy-5-methyl-1,1a,2,5,8,8a,8b-heptahydroazilidino<2',3':3,4>pyrrolo<1,2-a>indole-4,7-dione

<1aS-(1aα,8β,8aα,8bα)>-8<<(aminocarbonyl)oxy>methyl>-6-(isobutyloxy)imino-8a-methoxy-5-methyl-1,1a,2,5,8,8a,8b-heptahydroazilidino<2',3':3,4>pyrrolo<1,2-a>indole-4,7-dione

Conditions
ConditionsYield
With triethylamine In methanol for 18h; Ambient temperature;30%
O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

mitomycin A
4055-39-4

mitomycin A

8-{[(aminocarbonyl) oxy]methyl}-6-[(isobutyloxy)imino]-8a-methoxy-5-methyl1,1a,2,5,6,8,8a,8b-octahydro-azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione
114429-87-7

8-{[(aminocarbonyl) oxy]methyl}-6-[(isobutyloxy)imino]-8a-methoxy-5-methyl1,1a,2,5,6,8,8a,8b-octahydro-azirino[2',3':3,4]pyrrolo[1,2-a]indole-4,7-dione

Conditions
ConditionsYield
With triethylamine In methanol29.6%
O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

N-Cyanoguanidine
127099-85-8, 780722-26-1

N-Cyanoguanidine

Isobutyloxy-diguanid
98962-02-8

Isobutyloxy-diguanid

Conditions
ConditionsYield
In ethanol
O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

ethyl 2-chloronicotinate
1452-94-4

ethyl 2-chloronicotinate

ethyl 2-(isobutoxyamino)nicotinate
686267-50-5

ethyl 2-(isobutoxyamino)nicotinate

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In 1,4-dioxane at 140℃; for 24h;
(E)-tert-butyl (4-acetamido-3,5-dichlorobenzylamino)(3-(4-methoxyphenyl)-3-oxopropanamido)methylenecarbamate
951676-43-0

(E)-tert-butyl (4-acetamido-3,5-dichlorobenzylamino)(3-(4-methoxyphenyl)-3-oxopropanamido)methylenecarbamate

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

(E)-N-((4-acetamido-3,5-dichlorobenzylamino)-(amino)methylene)-3-(isobutoxyimino)-3-(4-methoxyphenyl)propanamide

(E)-N-((4-acetamido-3,5-dichlorobenzylamino)-(amino)methylene)-3-(isobutoxyimino)-3-(4-methoxyphenyl)propanamide

Conditions
ConditionsYield
In ethanol at 80℃; for 2h;
7-fluoro-4-oxo-4H-chromene-2-carboxylic acid {1-[3-fluoro-4-(2-oxo-ethoxy)-benzyl]-piperidin-4-yl}-amide
865450-71-1

7-fluoro-4-oxo-4H-chromene-2-carboxylic acid {1-[3-fluoro-4-(2-oxo-ethoxy)-benzyl]-piperidin-4-yl}-amide

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

C28H31F2N3O5

C28H31F2N3O5

Conditions
ConditionsYield
In methanol at 20℃;
O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

4-fluorobenzaldehyde
459-57-4

4-fluorobenzaldehyde

4-fluorobenzaldehyde O-isobutyloxime

4-fluorobenzaldehyde O-isobutyloxime

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

4-methoxy-phenyl-sulphonyl chloride
98-68-0

4-methoxy-phenyl-sulphonyl chloride

N1-isobutoxy-4-methoxy-1-benzenesulfonamide

N1-isobutoxy-4-methoxy-1-benzenesulfonamide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine In tetrahydrofuran
1-[2-methyl-8-2,4,6-trimethyl-phenyl)quinolin4-yl]-propan-1-one

1-[2-methyl-8-2,4,6-trimethyl-phenyl)quinolin4-yl]-propan-1-one

1-[2-Methyl-8-(2,4,6-trimethyl-phenyl)-quinolin-4-yl]-propan-1-one (E)-O-methyl-oxime
342431-74-7

1-[2-Methyl-8-(2,4,6-trimethyl-phenyl)-quinolin-4-yl]-propan-1-one (E)-O-methyl-oxime

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

1-[2-Methyl-8-(2,4,6-trimethyl-phenyl)-quinolin-4-yl]-propan-1-one O-isobutyl-oxime
342431-81-6

1-[2-Methyl-8-(2,4,6-trimethyl-phenyl)-quinolin-4-yl]-propan-1-one O-isobutyl-oxime

Conditions
ConditionsYield
With sodium acetate; potassium carbonate In ethanol; hexane
2',4'-dichloro-2-(pyridin-3-yl)-acetophenone
83227-42-3

2',4'-dichloro-2-(pyridin-3-yl)-acetophenone

O-isobutylhydroxylamine hydrochloride
6084-58-8

O-isobutylhydroxylamine hydrochloride

2',4'-Dichloro-2-(3-pyridyl)acetophenone O-isobutyloxime

2',4'-Dichloro-2-(3-pyridyl)acetophenone O-isobutyloxime

Conditions
ConditionsYield
With sodium carbonate In ethanol

6084-58-8Relevant articles and documents

Design, synthesis and evaluation of wound healing activity for β-sitosterols derivatives as potent Na+/K+-ATPase inhibitors

Cui, Shaoyu,Jiang, Hongli,Chen, Lei,Xu, Jian,Sun, Wenzhuo,Sun, Haopeng,Xie, Zijian,Xu, Yunhui,Yang, Fubai,Liu, Wenyuan,Feng, Feng,Qu, Wei

, (2020/01/31)

β-Sitosterols, is a common steroid that can be identified in a variety of plants and their efficacy in promoting wound healing has been demonstrated. Na+/K+-ATPase, more than a pump, its signal transduction function for involvement in cell growth regulation attracts widespread concern. The Na+/K+-ATPase/Src receptor complex can serve as a receptor involved in multiple signaling pathways including promoting wound healing pathways. To finding potent accelerating wound healing small molecular, we choose the high inhibitory activity of Na+/K+-ATPase and non-cardiotoxic natural compound, β-sitosterol as the substrate. A series of β-sitosterol derivatives were designed, synthesized and evaluated as potential Na+/K+-ATPase inhibitors. Among them, compounds 31, 47, 49, showed improved inhibitory activity on Na+/K+-ATPase, with IC50 value of 3.0 μM, 3.4 μM, 2.2 μM, which are more potent than β-sitosterol with IC50 7.6 μM. Especially, compound 49 can induce cell proliferation, migration and soluble collagen production in L929 fibroblasts. Compared to model, compound 49 can accelerate wound healing in SD rats. Further studies indicated that 49 can activate the sarcoma (Src), uptake the protein kinase B (Akt), extracellular signal-regulated kinase (ERK) proteins expression in a concentration dependent manner. Finally, binding mode of compound 49 with Na+/K+-ATPase was studied, which provides insights into the determinants of potency and selectivity. These results proved β-stitosterol derivative 49 can serve as an effective inhibitor of Na+/K+-ATPase and potential candidate for accelerating wound healing agents.

Tandem Functionalization in a Highly Branched Polymer with Layered Structure

Cao, Xiaosong,Shi, Yi,Gan, Weiping,Gao, Haifeng

supporting information, p. 5974 - 5981 (2018/03/26)

A hyperbranched polymer with multilayer structure was developed to demonstrate the possibility of highly efficient tandem functionalization reactions at different domains within one nanostructured platform. The polymer scaffold was constructed by chain-growth copper-catalyzed azide–alkyne cycloaddition polymerization of three functional monomers with sequential monomer addition in one pot. Subsequent reactions with different monomer units resulted in efficient functionalization of each segment with construction of a highly sophisticated polymer structure by a robust procedure. As a proof of concept, the ability of this polymer structure to quantitatively load six species of guest molecules through three different types of conjugation reactions was demonstrated.

NOVEL VASCULAR LEAKAGEAGE INHIBITOR

-

Paragraph 0102, (2015/01/07)

The present disclosure relates to a novel vascular leakage inhibitor. The novel vascular leakage inhibitor of the present invention inhibits the apoptosis of vascular endothelial cells, inhibits the formation of actin stress fibers induced by VEGF, and enhances the cortical actin ring structure, thereby inhibiting vascular leakage. Accordingly, the vascular leakage inhibitor of the present invention can prevent or treat various diseases caused by vascular leakage. Since the vascular leakage inhibitor of the present invention is synthesized from commercially available or easily synthesizable pregnenolones, it has remarkably superior feasibility of commercial synthesis.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 6084-58-8